Rule 10, Drugs and Cosmetics Rules, 1945
Drugs and Cosmetics Rules, 1945 - Rule 10
Text of rule 10
10. — Prohibition of import of certain drugs or cosmetics.
10A. Power of Central Government to prohibit import of drugs and
cosmetics in public interest.
11. Application of law relating to sea customs and powers of
Customs officers.
12. Power of Central Government to make rules.
13. Offences.
14. Confiscation.
15. Jurisdiction.
Drugs and Cosmetics Act, 1940
4
CHAPTER IV
MANUFACTURE, SALE AND DISTRIBUTION OF DRUGS AND
COSMETICS
Sections
16. Standards of quality.
17. Misbranded drugs.
17A. Adulterated drugs.
17B. Spurious drugs.
17C. Misbranded cosmetics.
17D. Spurious cosmetics.
18. Prohibition of manufacture and sale of certain drugs
and cosmetics.
18A. Disclosure of the name of the manufacturer, etc.
18B. Maintenance of records and furnishing of information.
19. Pleas.
20. Government Analysts.
21. Inspectors.
22. Powers of Inspectors.
23. Procedure of Inspectors.
24. Persons bound to disclose place where drugs or cosmetics
are manufactured or kept.
25. Reports of Government Analysts.
26. Purchaser of drug or cosmetic enabled to obtain test or analysis.
26A. Power of Central Government to prohibit manufacture, etc.,
of drug and cosmetic in public interest.
27. Penalty for manufacture, sale, etc., of drugs in contravention
of this Chapter.
27A. Penalty for manufacture, sale, etc., of cosmetics in
contravention of this Chapter.
28. Penalty for non-disclosure of the name of the manufacturer, etc.
28A. Penalty for not keeping documents, etc., and for non-disclosure
of information.
28B. Penalty for manufacture, etc. of drugs or cosmetics
in contravention of section 26A.
29. Penalty for use of Government Analyst‘s report for advertising.
30. Penalty for subsequent offences.
31. Confiscation.
31A. Application of provisions to Government departments.
32. Cognizance of offences.
32A. Power of Court to implead the manufacturer, etc.
33. Power of Central Government to make rules.
33A. Chapter not to apply to Ayurvedic, Siddha or Unani drugs.
CHAPTER IV A
PROVISIONS RELATING TO AYURVEDIC SIDDHA AND UNANI DRUGS
33B. Application of Chapter IV A.
Drugs and Cosmetics Act, 1940
CHAPTER IV
MANUFACTURE, SALE AND DISTRIBUTION OF DRUGS AND
Sections
16.
17.
17A.
17B.
17C.
17D.
18.
18A.
18B.
19.
20.
21.
22.
23.
24.
25.
26
26A.
27.
27A.
28
28A.
28B.
29.
30.
31
31A.
32
32A.
33
33A.
COSMETICS
Standards of quality.
Misbranded drugs.
Adulterated drugs.
Spurious drugs.
Misbranded cosmetics.
Spurious cosmetics.
Prohibition of manufacture and sale of certain drugs
and cosmetics.
Disclosure of the name of the manufacturer, etc.
Maintenance of records and furnishing of information.
Pleas.
Government Analysts.
Inspectors.
Powers of Inspectors.
Procedure of Inspectors.
Persons bound to disclose place where drugs or cosmetics
are manufactured or kept.
Reports of Government Analysts.
Purchaser of drug or cosmetic enabled to obtain test or analysis.
Power of Central Government to prohibit manufacture, etc.,
of drug and cosmetic in public interest.
Penalty for manufacture, sale, etc., of drugs in contravention
of this Chapter.
Penalty for manufacture, sale, etc., of cosmetics in
contravention of this Chapter.
Penalty for non-disclosure of the name of the manufacturer, etc.
Penalty for not keeping documents, etc., and for non-disclosure
of information.
Penalty for manufacture, etc. of drugs or cosmetics
in contravention of section 26A.
Penalty for use of Government Analyst’s report for advertising.
Penalty for subsequent offences.
Confiscation.
Application of provisions to Government departments.
Cognizance of offences.
Power of Court to implead the manufacturer, etc.
Power of Central Government to make rules.
Chapter not to apply to Ayurvedic, Siddha or Unani drugs.
CHAPTERIVA
PROVISIONS RELATING TO AYURVEDIC SIDDHA AND UNANI DRUGS
33B. Application of Chapter IV A.
4
Drugs and Cosmetics Act, 1940
5
Sections
33C. Ayurvedic, Siddha and Unani Drugs Technical
Advisory Board.
33D. The Ayurvedic, Siddha and Unani Drugs Consultative
Committee.
33E. Misbranded drugs.
33EE. Adulterated drugs.
33EEA. Spurious drugs.
33EEB. Regulation of manufacture for sale of Ayurvedic,
Siddha and Unani drugs.
33EEC. Prohibition of manufacture and sale of certain
Ayurvedic, Siddha and Unani drugs.
33EED. Power of Central Government to prohibit manufacture,
etc., of Ayurvedic, Siddha or Unani drugs in public
interest.
33F. Government Analysts.
33G. Inspectors.
33H. Application of provisions of sections 22, 23, 24 and
25.
33-I. Penalty for manufacture, sale, etc., of Ayurvedic,
Siddha or Unani drugs in contravention of this
Chapter.
33J. Penalty for subsequent offences.
33K. Confiscation.
33L. Application of provisions to Government departments.
33M. Cognizance of offences.
33N. Power of Central Government to make rules.
33O. Power to amend First Schedule.
CHAPTER V
MISCELLANEOUS
33P. Power to give directions.
34. Offences by companies.
34A. Offences by Government departments.
34AA. Penalty vexatious search or seizure.
35. Publication of sentences passed under this Act.
36. Magistrate‘s power to impose enhanced penalties.
36A. Certain offences to be tried summarily.
37. Protection of action taken in good faith.
38. Rules to be laid before Parliament.
THE FIRST SCHEDULE.
THE SECOND SCHEDULE.
Sections
33C,
33D.
33E.
33EE.,
33EEA.
33EEB.
33EEC.
33EED.
33F.
33G.
33H.
33-I.
33J.
33K.
33L.
33M.
33N.
330.
33P.
34.
34A.
34AA.
35.
36.
36A.
37.
38.
Drugs and Cosmetics Act, 1940
Ayurvedic, Siddha and Unani Drugs Technical
Advisory Board.
The Ayurvedic, Siddha and Unani Drugs Consultative
Committee.
Misbranded drugs.
Adulterated drugs.
Spurious drugs.
Regulation of manufacture for sale of Ayurvedic,
Siddha and Unani drugs.
Prohibition of manufacture and sale of certain
Ayurvedic, Siddha and Unani drugs.
Power of Central Government to prohibit manufacture,
etc., of Ayurvedic, Siddha or Unani drugs in public
interest.
Government Analysts.
Inspectors.
Application of provisions of sections 22, 23, 24 and
25.
Penalty for manufacture, sale, etc., of Ayurvedic,
Siddha or Unani drugs in contravention of this
Chapter.
Penalty for subsequent offences.
Confiscation.
Application of provisions to Government departments.
Cognizance of offences.
Power of Central Government to make rules.
Power to amend First Schedule.
CHAPTER V
MISCELLANEOUS
Power to give directions.
Offences by companies.
Offences by Government departments.
Penalty vexatious search or seizure.
Publication of sentences passed under this Act.
Magistrate’s power to impose enhanced penalties.
Certain offences to be tried summarily.
Protection of action taken in good faith.
Rules to be laid before Parliament.
THE FIRST SCHEDULE.
THE SECOND SCHEDULE.
6
1 Drugs and Cosmetics Act, 1940
THE DRUGS AND COSMETICS ACT, 1940
(23 OF 1940)
1
[10th April, 1940.]
An Act to regulate the import, manufacture, distribution and sale of drugs
2
[and cosmetics];
WHEREAS it is expedient to regulate the
3
[import, manufacture, distribution and sale] of drugs
2
[and
cosmetics];
AND WHEREAS the Legislature of all the Provinces have passed resolutions in terms of section 103
of the Government of India Act, 1935 (26 Geo. 5, c.2), in relation to such of the above-mentioned
matters and matters ancillary thereto as are enumerated in List II of the Seventh Schedule to the said Act;
It is hereby enacted as follows:-
CHAPTER I
INTRODUCTORY
1. Short title, extent and commencement.⎯ (1) This Act may be called the Drugs
2
[and Cosmetics]
Act, 1940.
(2) It extends to the whole of India
4
[
* * *].
(3) It shall come into force at once; but Chapter III shall take effect only from such date
5 as the
Central Government may, by notification in the Official Gazette, appoint in this behalf, and Chapter IV shall
take effect in a particular State only from such date
5 as the State Government may, by like notification,
appoint in this behalf:
6
[Provided that in relation to the State of Jammu and Kashmir, Chapter III shall take effect only from
such date
10
after the commencement of the Drugs and Cosmetics (Amendment) Act, 1972 (19 of 1972), as
the Central Government may, by notification in the Official Gazette, appoint in this behalf.]
2. Application of other laws not barred.- The provisions of this Act shall be in addition to and not in
derogation of, the Dangerous Drugs Act, 1930 (2 of 1930), and any other law for the time being in force.
3. Definitions.—In this Act, unless there is anything repugnant in the subject or context,
7
[(a) ―
8
[Ayurvedic, Siddha or Unani] drug‖ includes all medicines intended for internal or external use
for or in the diagnosis, treatment, mitigation or prevention of
8
[disease or disorder in human beings or
animals, and manufactured] exclusively in accordance with the formulae described in, the authoritative
books of
9
[Ayurvedic, Siddha and Unani Tibb systems of medicine], specified in the First Schedule;]
9
[(aa) ―the Board‖ means—
(i) in relation to
9
[Ayurvedic, Siddha or Unani] drug, the
9
[Ayurvedic, Siddha and Unani
Drugs Technical Advisory Board] constituted under section 33C; and
(ii) in relation to any other drug or cosmetic, the Drugs Technical Advisory Board
constituted under section 5;]
1. For Statement of Object and Reasons, see Gazette of India, 1940, Pt. V, p. 34; for the Report of the Select Committee, see ibid., p. 143.
The Act has been applied to all the partially excluded areas in the State of Orissa, see Orissa Government Notification No. 3358-LSG., dated the 25th
August, 1941.
2. Ins. by Act 21 of 1962, s. 2 (w.e.f. 27-7-1964).
3. Subs. by the A.O. 1950, for certain words.
4. The words ―except the State of Jammu and Kashmir‖ omitted by Act 19 of 1972, s .2. (w.e.f. 31-5-1972).
5 1st April, 1947; see Notifn. No. F. 28 (10) (3) 45-H (1), dated the 2nd September 1946, Gazette of India, 1946, Pt. I, p.1349.
Chapter IV came into force in the States of Delhi, Ajmer and Coorg on the 1st April, 1947, see ibid., Chapters III and IV came into force in the
States of Himachal Pradesh, Bilaspur, Kutch, Bhopal, Tripura, Vindhya Pradesh and Manipur on the 1st April, 1953, vide Notification No. S.R.O.
663, dated the 30th March, 1953, Gazette of India, Pt. II, Sec. 3, p. 451.
Chapter IV came into force in the Union territory of Dadra and Nagar Haveli w.e.f. 1st August, 1968, see Notification No. ADM/Law/117(74),
dated the 20th July, 1968, Gazette of India, Pt. III, Sec. 3, p.128. The Act is extended to Dadra and Nagar Haveli by Reg. 6 of 1963, s. 2 and Sch.
I; to Pondicherry by Reg. 7 of 1963. s. 3 and Sch. I; to Goa, Daman and Diu by Reg. 11 of 1963, s. 3 and Sch. and to Laccadive, Minicoy and
Amindivi Islands by Reg. 8 of 1965. s.3 and Sch.
6. Added by Act 19 of 1972, s. 2.
7 Ins. by Act 13 of 1964, s. 2 (w.e.f. 15-9-1964).
8. Subs. by Act 68 of 1982, s. 2, for certain words (w.e.f. 1-2-1983).
9. Clause. (a) was relettered as cl. (aa) by Act 13 of 1964 s. 2, (w.e.f. 15-9-1964).
10. 24th August, 1974, vide notifin no. S.O. 2185, dt. 9th August, 1974.
THE DRUGS AND COSMETICS ACT, 1940
(23 OF 1940)
[10th April, 1940.]
2
An Act to regulate the import, manufacture, distribution and sale of drugs [and cosmetics];
3 2
WHEREAS it is expedient to regulate the [import, manufacture, distribution and sale] of drugs [and
cosmetics];
AND WHEREAS the Legislature of all the Provinces have passed resolutions in terms of section 103
of the Government of India Act, 1935 (26 Geo. 5, c.2), in relation to such of the above-mentioned
matters and matters ancillary thereto as are enumerated in List II of the Seventh Schedule to the said Act;
It is hereby enacted as follows:-
CHAPTER I
INTRODUCTORY
2
1. Short title, extent and commencement.— (1) This Act may be called the Drugs [and Cosmetics]
Act, 1940.
(2) It extends to the whole of India “[ * * *].
5
(3) It shall come into force at once; but Chapter III shall take effect only from such date as the
Central Government may, by notification in the Official Gazette, appoint in this behalf, and Chapter IV shall
5
take effect in a particular State only from such date as the State Government may, by like notification,
appoint in this behalf:
6
[Provided that in relation to the State of Jammu and Kashmir, Chapter III shall take effect only from
such date'’ after the commencement of the Drugs and Cosmetics (Amendment) Act, 1972 (19 of 1972), as
the Central Government may, by notification in the Official Gazette, appoint in this behalf.]
2. Application of other laws not barred.- The provisions of this Act shall be in addition to and not in
derogation of, the Dangerous Drugs Act, 1930 (2 of 1930), and any other law for the time being in force.
3. Definitions.—In this Act, unless there is anything repugnant in the subject or context,
7
[(a) ““[Ayurvedic, Siddha or Unani] drug” includes all medicines intended for internal or external use
8
for or in the diagnosis, treatment, mitigation or prevention of [disease or disorder in human beings or
animals, and manufactured] exclusively in accordance with the formulae described in, the authoritative
9
books of [Ayurvedic, Siddha and Unani Tibb systems of medicine], specified in the First Schedule;]
9
[(aa) “the Board” means—
(i) in relation to “TAyurvedic, Siddha or Unani] drug, the “TAyurvedic, Siddha and Unani
Drugs Technical Advisory Board] constituted under section 33C; and
(ii) in relation to any other drug or cosmetic, the Drugs Technical Advisory Board
constituted under section 5;]
1. For Statement of Object and Reasons, see Gazette of India, 1940, Pt. V, p. 34; for the Report of the Select Committee, see ibid., p. 143.
The Act has been applied to all the partially excluded areas in the State of Orissa, see Orissa Government Notification No. 3358-LSG., dated the 25"
August, 1941.
2. Ins. by Act 21 of 1962, s. 2 (w.e.f. 27-7-1964).
3. Subs. by the A.O. 1950, for certain words.
4. The words “except the State of Jammu and Kashmir” omitted by Act 19 of 1972, s .2. (w.e.f. 31-5-1972).
5 1 April, 1947; see Notifn. No. F. 28 (10) (3) 45-H (1), dated the 2" September 1946, Gazette of India, 1946, Pt. I, p.1349.
Chapter IV came into force in the States of Delhi, Ajmer and Coorg on the 1* April, 1947, see ibid., Chapters IIT and IV came into force in the
States of Himachal Pradesh, Bilaspur, Kutch, Bhopal, Tripura, Vindhya Pradesh and Manipur on the 1* April, 1953, vide Notification No. S.R.O.
663, dated the 30" March, 1953, Gazette of India, Pt. II, Sec. 3, p. 451.
Chapter IV came into force in the Union territory of Dadra and Nagar Haveli w.e.f. 1 August, 1968, see Notification No. ADM/Law/117(74),
dated the 20" July, 1968, Gazette of India, Pt. III, Sec. 3, p.128. The Act is extended to Dadra and Nagar Haveli by Reg. 6 of 1963, s. 2 and Sch.
I; to Pondicherry by Reg. 7 of 1963. s. 3 and Sch. I; to Goa, Daman and Diu by Reg. 11 of 1963, s. 3 and Sch. and to Laccadive, Minicoy and
Amindivi Islands by Reg. 8 of 1965. s.3 and Sch.
6. Added by Act 19 of 1972, s. 2.
7 Ins. by Act 13 of 1964, s. 2 (w.e.f. 15-9-1964).
8. Subs. by Act 68 of 1982, s. 2, for certain words (w.e.f. 1-2-1983).
9. Clause. (a) was relettered as cl. (aa) by Act 13 of 1964s. 2, (w.e.f. 15-9-1964).
10. 24" August, 1974, vide notifin no. S.O. 2185, dt. 9" August, 1974.
Drugs and Cosmetics Act, 1940
7
1
[
2
[(aaa)] ―cosmetic‖ means any article intended to be rubbed, poured, sprinkled or sprayed on, or
introduced into, or otherwise applied to, the human body or any part thereof for cleansing, beautifying,
promoting attractiveness, or altering the appearance, and includes any article intended for use as a component
of cosmetic
3
[* * *] ;]
4
[(b) ―drug‖ includes—
5
[(i) all medicines for internal or external use of human beings or animals and all substances
intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder
in human beings or animals, including preparations applied on human body for the purpose of repelling
insects like mosquitoes;]
(ii) such substances (other than food) intended to affect the structure or any function of the human
body or intended to be used for the destruction of
6
[vermin] or insects which cause disease in human
beings or animals, as may be specified from time to time by the Central Government by notification in
the Official Gazette;]
7
[(iii) all substances intended for use as components of a drug including empty gelatin capsules; and
(iv) such devices* intended for internal or external use in the diagnosis, treatment, mitigation or
prevention of disease or disorder in human beings or animals, as may be specified from time to time by
the Central Government by notification in the Official Gazette, after consultation with the Board;]
8
[(c) ―Government Analyst‖ means—
(i) in relation to
9
[Ayurvedic, Siddha or Unani] drug, a Government Analyst appointed by the
Central Government or a State Government under section 33F; and
(ii) in relation to any other drug or cosmetic, a Government Analyst appointed by the Central
Government or a State Government under section 20;]
10
[* * * * *]
11
[(e) ―Inspector‖ means—
(i) in relation to
9
[Ayurvedic, Siddha or Unani] drug, an Inspector appointed by the Central
Government or a State Government under section 33G; and
(ii) in relation to any other drug or cosmetic, an Inspector appointed by the Central Government
or a State Government under section 21;]
12
[
13
[(f)] ―manufacture‖ in relation to any drug
14
[or cosmetic] includes any process or part of a
process for making, altering, ornamenting, finishing, packing, labelling, breaking up or otherwise
treating or adopting any drug
14
[or cosmetic] with a view to its
15
[sale or distribution] but does not
include the compounding or dispensing
16
[of any drug, or the packing of any drug or cosmetic,] in
the ordinary course of retail business; and ―to manufacture‖ shall be construed accordingly;]
17
[(g)] ―to import‖, with its grammatical variations and cognate expressions means to bring into
18
[India];
1. Ins. by Act 21 of 1962, s. 4 (w.e.f. 27-7-1964).
2. Clause. (aa) relettered by Act 13 of 1964, s. 2 (w.e.f. 15-9-1964).
3. omitted by Act 68 of 1982, s.3, certain words.
4. Subs. by Act 11 of 1955, s. 2, for cl. (b).
5. Subs. by Act 68 of 1982, s. 3 (w.e.f. 1-2-1983).
6. Subs. by Act 13 of 1964, s. 2, for ―vermins‖ (w.e.f. 15-9-1964).
7. Ins. by Act 68 of 1982, s.3 (w.e.f. 1-2-1983).
The Central Government has specified (vide S.O. 1468 (E), dated 6-10-2005) the following devices intended for external or internal use in human
beings or drugs with immediate effect, namely:-
(i) Cardiac Stents (ii) Drug Eluding Stents (iii) Catheters (iv) Intra Ocular Lenses (v) I.V. Cannulac (vi) Bone Cements
(vii) Heart Valves (viii) Scalp Vein Set (ix) Orthopaedic Implants (x) Internal Prosthetic Replacements
8. Subs. by Act 13 of 1964, s. 2, for cl. (c) (w.e.f.15-9-1964).
9. Subs. by Act 68 of 1982 s.2, for ―Ayurvedic (including sidda) or Unani‖ (w.e.f. 1-2-1983).
10. Cl. (d) omitted by Act 19 of 1972, s. 3. 15. Subs. by Act 68 of 1982, s.3, for ―sale and distribution‖(w.e.f. 1-2-1983).
11. Subs. by Act 13 of 1964, s. 2, for cl. (e) (w.e.f. 15-9-1964). 16. Subs. by Act 21 of 1962 s. 4, for ―or the packing of any drug‖.
12. Ins. by Act 11 of 1955, s. 2. 17. Cls.(c), (d) and (e) relettered as cls. (g), (h) and (i) respectively by Act 35 of 1960, s. 2 (w.e.f. 16-3-1961).
13. Clause. (bbb) relettered as cl. (f) by Act 35 of 1960, s. 2 (w.e.f. 16-3-1961).
14. Ins. by Act 21 of 1962, s. 4 (w.e.f. 27-7-1964). 18. Subs. by Act 3 of 1951, s. 3 and Sch., for ―the States‖.
Drugs and Cosmetics Act, 1940
12
[ [(aaa)] “cosmetic” means any article intended to be rubbed, poured, sprinkled or sprayed on, or
introduced into, or otherwise applied to, the human body or any part thereof for cleansing, beautifying,
promoting attractiveness, or altering the appearance, and includes any article intended for use as a component
3
of cosmetic [* * *] ;]
4
[(b) “drug” includes—
5
[(i) all medicines for internal or external use of human beings or animals and all substances
intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder
in human beings or animals, including preparations applied on human body for the purpose of repelling
insects like mosquitoes; ]
(ii) such substances (other than food) intended to affect the structure or any function of the human
body or intended to be used for the destruction of [vermin] or insects which cause disease in human
beings or animals, as may be specified from time to time by the Central Government by notification in
the Official Gazette; ]
7
[(iii) all substances intended for use as components of a drug including empty gelatin capsules; and
(iv) such devices* intended for internal or external use in the diagnosis, treatment, mitigation or
prevention of disease or disorder in human beings or animals, as may be specified from time to time by
the Central Government by notification in the Official Gazette, after consultation with the Board;]
[(c) “Government Analyst” means—
9
(i) in relation to [Ayurvedic, Siddha or Unani] drug, a Government Analyst appointed by the
Central Government or a State Government under section 33F; and
(ii) in relation to any other drug or cosmetic, a Government Analyst appointed by the Central
Government or a State Government under section 20;]
10
[x * * * *]
ul
[(e) “Inspector” means—
9
(i) in relation to [Ayurvedic, Siddha or Unani] drug, an Inspector appointed by the Central
Government or a State Government under section 33G; and
(ii) in relation to any other drug or cosmetic, an Inspector appointed by the Central Government
or a State Government under section 215]
12 13 14
| [@] “manufacture” in relation to any drug [or cosmetic] includes any process or part of a
process for making, altering, ornamenting, finishing, packing, labelling, breaking up or otherwise
14 15
treating or adopting any drug [or cosmetic] with a view to its [sale or distribution] but does not
16
include the compounding or dispensing [of any drug, or the packing of any drug or cosmetic, ] in
the ordinary course of retail business; and “to manufacture” shall be construed accordingly; ]
"[(2)] “to import”, with its grammatical variations and cognate expressions means to bring into
[India];
Ins. by Act 21 of 1962, s. 4 (w.e.f. 7-7-1964).
Clause. (aa) relettered by Act 13 of 1964, s. 2 (w.e.f. 15-9-1964).
omitted by Act 68 of 1982, s.3, certain words.
Subs. by Act 11 of 1955, s. 2, for cl. (b).
Subs. by Act 68 of 1982, s. 3 (w.e.f. 1-2-1983).
Subs. by Act 13 of 1964, s.2, for “vermins” (w.e.f. 15-9-1964).
Ins. by Act 68 of 1982, 5.3 (w.e.f. 1-2-1983).
The Central Government has specified (vide S.O. 1468 (E), dated 6-10-2005) the following devices intended for external or internal use in human
beings or drugs with immediate effect, namely:-
(i) Cardiac Stents (ii) Drug Eluding Stents (ili) Catheters (iv) Intra Ocular Lenses (v) IV. Cannulac (vi) Bone Cements
(vil) Heart Valves (vii) Scalp Vein Set (ix) Orthopaedic Implants —_ (x) Internal Prosthetic Replacements
Subs. by Act 13 of 1964, s. 2, for cl. (c) (w.e.f.15-9-1964).
Subs. by Act 68 of 1982 s.2, for “Ayurvedic (including sidda) or Unani” (w.e.f. 1-2-1983).
Cl. (d) omitted by Act 19 of 1972, s. 3. 15. Subs. by Act 68 of 1982, s.3, for “sale and distribution’ (w.e.f. 1-2-1983).
. Subs. by Act 13 of 1964, s. 2, for cl. (e) (w.e.f. 15-9-1964). 16. Subs. by Act 21 of 1962 s.4, for “or the packing of any drug”.
. Ins. by Act 11 of 1955, s. 2. 17. Cls.(c), (d) and (e) relettered as cls. (g), () and (i) respectively by Act 35 of 1960, s. 2 (w.e.f. 16-3-1961).
. Clause. (bbb) relettered as cl. (f) by Act 35 of 1960, s. 2 (w.e.f. 16-3-1961).
. Ins. by Act 21 of 1962, s. 4 (w.e.f. 27-7-1964). 18. Subs. by Act 3 of 1951, s. 3 and Sch., for “the States”.
Drugs and Cosmetics Act, 1940
8
1
[
2
[(h)] ―patent or proprietary medicine‖ means,—
(i) in relation to Ayurvedic, Siddha or Unani Tibb systems of medicine all formulations containing only
such ingredients mentioned in the formulae described in the authoritative books of Ayurveda, Siddha or Unani
Tibb systems of medicine specified in the First Schedule, but does not include a medicine which is
administered by parenteral route and also a formulation included in the authoritative books as specified in
clause (a);
(ii) in relation to any other systems of medicine, a drug which is a remedy or prescription presented in
a form ready for internal or external administration of human beings or animals and which is not included in
the edition of the Indian Pharmacopoeia for the time being or any other Pharmacopoeia authorised in this
behalf by the Central Government after consultation with the Drugs Technical Advisory Board constituted
under section 5;]
3
[
2
[(i)] ―prescribed‖ means prescribed by rules made under this Act.]
4
[* * * * *]
5
[3A. Construction of references to any law not in force or any functionary not in existence in the
State of Jammu and Kashmir.—Any reference in this Act to any law which is not in force, or any
functionary not in existence, in the State of Jammu and Kashmir, shall, in relation to that State, be construed
as a reference to the corresponding law in force, or to the corresponding functionary in existence, in that
State.]
4. Presumption as to poisonous substances.—Any substance specified as poisonous by rule made under
Chapter III or Chapter IV
6
[or Chapter IVA] shall be deemed to be a poisonous substance for the purposes of
Chapter III or Chapter IV
6
[or Chapter IVA], as the case may be.
CHAPTER II
THE DRUGS TECHNICAL ADVISORY BOARD, THE CENTRAL DRUGS LABOURATORY
AND THE DRUGS CONSULTATIVE COMMITTEE
5. The Drugs Technical Advisory Board.—(1) The Central Government shall, as soon as may be,
constitute a Board (to be called the Drugs Technical Advisory Board) to advise the Central Government and
the State Governments on technical matters arising out of the administration of this Act and to carry out the
other functions assigned to it by this Act.
7
[(2) The Board shall consist of the following members, namely:—
(i) the Director General of Health Services, ex officio, who shall be Chairman; (ii) the Drugs
Controller, India, ex officio;
(iii) the Director of the Central Drugs Laboratory, Calcutta, ex officio;
(iv) the Director of the Central Research Institute, Kasauli, ex officio;
(v) the Director of Indian Veterinary Research Institute, Izatnagar, ex officio;
(vi) the President of Medical Council of India, ex officio;
(vii) the President of the Pharmacy Council of India, ex officio;
(viii) the Director of Central Drug Research Institute, Lucknow, ex officio;
(ix) two persons to be nominated by the Central Government from among persons who are in
charge of drugs control in the States;
1. Subs. by Act 68 of 1982, s. 3, for cl. (h) (w.e.f. 1-2-1983).
2. Cls. (c), (d) and (e) relettered as cls. (g), (h) and (i) respectively by Act 35 of 1960, s. 2 (w.e.f. 16-3-1961).
3. Subs. by Act 11 of 1955, s. 2, for cl. (e).
4. Clause. (f) ins. by the A.O. 1950 and omitted by Act 3 of 1951, s. 3 and Sch.
5. Ins. by Act 19 of 1972, s. 4 (w.e.f. 31-5-1972).
6. Ins. by Act 13 of 1964, s. 3 (w.e.f. 15-9-1964).
7. Subs. by Act 13 of 1964, s. 4, for sub-section (2) (w.e.f. 15-9-1964).
Drugs and Cosmetics Act, 1940
12
[ [(h)] “patent or proprietary medicine” means,—
(i) in relation to Ayurvedic, Siddha or Unani Tibb systems of medicine all formulations containing only
such ingredients mentioned in the formulae described in the authoritative books of Ayurveda, Siddha or Unani
Tibb systems of medicine specified in the First Schedule, but does not include a medicine which is
administered by parenteral route and also a formulation included in the authoritative books as specified in
clause (a);
(ii) in relation to any other systems of medicine, a drug which is a remedy or prescription presented in
a form ready for internal or external administration of human beings or animals and which is not included in
the edition of the Indian Pharmacopoeia for the time being or any other Pharmacopoeia authorised in this
behalf by the Central Government after consultation with the Drugs Technical Advisory Board constituted
under section 5;]
32
[ [()] “prescribed” means prescribed by rules made under this Act. ]
5
[3A. Construction of references to any law not in force or any functionary not in existence in the
State of Jammu and Kashmir.—Any reference in this Act to any law which is not in force, or any
functionary not in existence, in the State of Jammu and Kashmir, shall, in relation to that State, be construed
as a reference to the corresponding law in force, or to the corresponding functionary in existence, in that
State. ]
4. Presumption as to poisonous substances.—Any substance specified as poisonous by rule made under
Chapter II or Chapter IV [or Chapter IVA] shall be deemed to be a poisonous substance for the purposes of
Chapter III or Chapter IV [or Chapter IVA], as the case may be.
CHAPTER II
THE DRUGS TECHNICAL ADVISORY BOARD, THE CENTRAL DRUGS LABOURATORY
AND THE DRUGS CONSULTATIVE COMMITTEE
5. The Drugs Technical Advisory Board.—(/) The Central Government shall, as soon as may be,
constitute a Board (to be called the Drugs Technical Advisory Board) to advise the Central Government and
the State Governments on technical matters arising out of the administration of this Act and to carry out the
other functions assigned to it by this Act.
7
[(2) The Board shall consist of the following members, namely:—
(i) the Director General of Health Services, ex officio, who shall be Chairman; (i7) the Drugs
Controller, India, ex officio;
(iii) the Director of the Central Drugs Laboratory, Calcutta, ex officio;
(iv) the Director of the Central Research Institute, Kasauli, ex officio;
(v) the Director of Indian Veterinary Research Institute, Izatnagar, ex officio;
(vi) the President of Medical Council of India, ex officio;
(vii) the President of the Pharmacy Council of India, ex officio;
(viii) the Director of Central Drug Research Institute, Lucknow, ex officio;
(ix) two persons to be nominated by the Central Government from among persons who are in
charge of drugs control in the States;
1. Subs. by Act 68 of 1982, s. 3, for cl. (A) (w.e.f. 1-2-1983).
2. Cls. (c), (d) and (e) relettered as cls. (g), (h) and (i) respectively by Act 35 of 1960, s.2 (w.e.f. 16-3-1961).
3. Subs. by Act 11 of 1955, s. 2, for cl. (e).
4. Clause. (f) ins. by the A.O. 1950 and omitted by Act 3 of 1951, s. 3 and Sch.
5. Ins. by Act 19 of 1972, s. 4 (w.e.f. 31-5-1972).
6. Ins. by Act 13 of 1964, s. 3 (w.e.f. 15-9-1964).
7. Subs. by Act 13 of 1964, s. 4, for sub-section (2) (w.e.f. 15-9-1964).
Drugs and Cosmetics Act, 1940
9
(x) one person, to be elected by the Executive Committee of the Pharmacy Council of India, from
among teachers in pharmacy or pharmaceutical chemistry or pharmacognosy on the staff of an
Indian university or a college affiliated thereto;
(xi) one person, to be elected by the Executive Committee of the Medical Council of India, from
among teachers in medicine or therapeutics on the staff of an Indian university or a college affiliated
thereto;
(xii) one person to be nominated by the Central Government from the pharmaceutical industry;
(xiii) one pharmacologist to be elected by the Governing Body of the Indian Council of Medical
Research;
(xiv) one person to be elected by the Central Council of the Indian Medical Association;
(xv) one person to be elected by the Council of the Indian Pharmaceutical Association;
(xvi) two persons holding the appointment of Government Analyst under this Act, to be
nominated by the Central Government.]
(3) The nominated and elected members of the Board shall hold office for three years, but shall be
eligible for re- nomination and re-election:
1
[Provided that the person nominated or elected, as the case may be, under clause (ix) or clause (x) or
clause (xi) or clause (xvi) of sub-section (2) shall hold office for so long as he holds the appointment of the
office by virtue of which he was nominated or elected to the Board.]
(4) The Board may, subject to the previous approval of the Central Government, make bye-laws fixing a
quorum and regulating its own procedure and the conduct of all business to be transacted by it.
(5) The Board may constitute sub-committees and may appoint to such sub-committees for such periods,
not exceeding three years, as it may decide, or temporarily for the consideration of particular matters,
persons who are not members of the Board.
(6) The functions of the Board may be exercised notwithstanding any vacancy therein.
(7) The Central Government shall appoint a person to be Secretary of the Board and shall provide the
Board with such clerical and other staff as the Central Government considers necessary.
6. The Central Drugs Laboratory.—(1) The Central Government shall, as soon as may be, established
a Central Drugs Laboratory under the control of a Director to be appointed by the Central Government, to
carry out the functions entrusted to it by this Act or any rules made under this Chapter:
Provided that, if the Central Government so prescribes, the functions of the Central Drugs Laboratory in
respect of any drug or class of drugs
2
[or cosmetic or class of cosmetics] shall be carried out at the Central
Research Institute, Kasauli, or at any other prescribed Laboratory and the functions of the Director of the
Central Drugs Laboratory in respect of such drug or class of drugs
2
[or such cosmetic or class of
cosmetics] shall be exercised by the Director of that Institute or of that other Laboratory, as the case may
be.
(2) the Central Government may, after consultation with the Board, make rules prescribing—
(a) the functions of the Central Drugs Laboratory;
3
[* * * * *]
(d) the procedure for the submission to the said Laboratory
4
[under Chapter IV or Chapter IVA] of
samples of drugs
2
[or cosmetics] for analysis or test, the forms of Laboratory‘s reports thereon and the
fees payable in respect of such reports;
1. Subs. by Act 13 of 1964, s. 4, for the proviso (w.e.f. 15-9-1964).
2. Ins. by Act 21 of 1962, s. 5 (w.e.f. 27-7-1964).
3. Cls. (b) and (c) omitted by Act 11 of 1955, s. 4.
4. Subs. by Act 13 of 1964, s. 5, for ―under Chapter IV‖ (w.e.f. 15-9-1964).
Drugs and Cosmetics Act, 1940
(x) one person, to be elected by the Executive Committee of the Pharmacy Council of India, from
among teachers in pharmacy or pharmaceutical chemistry or pharmacognosy on the staff of an
Indian university or a college affiliated thereto;
(xi) one person, to be elected by the Executive Committee of the Medical Council of India, from
among teachers in medicine or therapeutics on the staff of an Indian university or a college affiliated
thereto;
(xii) one person to be nominated by the Central Government from the pharmaceutical industry;
(xiii) one pharmacologist to be elected by the Governing Body of the Indian Council of Medical
Research;
(xiv) one person to be elected by the Central Council of the Indian Medical Association;
(xv) one person to be elected by the Council of the Indian Pharmaceutical Association;
(xvi) two persons holding the appointment of Government Analyst under this Act, to be
nominated by the Central Government. ]
(3) The nominated and elected members of the Board shall hold office for three years, but shall be
eligible for re- nomination and re-election:
1
[Provided that the person nominated or elected, as the case may be, under clause (ix) or clause (x) or
clause (xi) or clause (xvi) of sub-section (2) shall hold office for so long as he holds the appointment of the
office by virtue of which he was nominated or elected to the Board. ]
(4) The Board may, subject to the previous approval of the Central Government, make bye-laws fixing a
quorum and regulating its own procedure and the conduct of all business to be transacted by it.
(5) The Board may constitute sub-committees and may appoint to such sub-committees for such periods,
not exceeding three years, as it may decide, or temporarily for the consideration of particular matters,
persons who are not members of the Board.
(6) The functions of the Board may be exercised notwithstanding any vacancy therein.
(7) The Central Government shall appoint a person to be Secretary of the Board and shall provide the
Board with such clerical and other staff as the Central Government considers necessary.
6. The Central Drugs Laboratory.—(/) The Central Government shall, as soon as may be, established
a Central Drugs Laboratory under the control of a Director to be appointed by the Central Government, to
carry out the functions entrusted to it by this Act or any rules made under this Chapter:
Provided that, if the Central Government so prescribes, the functions of the Central Drugs Laboratory in
respect of any drug or class of drugs [or cosmetic or class of cosmetics] shall be carried out at the Central
Research Institute, Kasauli, or at any other prescribed Laboratory and the functions of the Director of the
2
Central Drugs Laboratory in respect of such drug or class of drugs [or such cosmetic or class of
cosmetics] shall be exercised by the Director of that Institute or of that other Laboratory, as the case may
be.
(2) the Central Government may, after consultation with the Board, make rules prescribing—
(a) the functions of the Central Drugs Laboratory;
3
[* * Ok * *]
4
(d) the procedure for the submission to the said Laboratory [under Chapter IV or Chapter IVA] of
samples of drugs [or cosmetics] for analysis or test, the forms of Laboratory’s reports thereon and the
fees payable in respect of such reports;
1. Subs. by Act 13 of 1964, s. 4, for the proviso (w.e.f. 15-9-1964).
2. Ins. by Act 21 of 1962, s. 5 (w.e.f. 27-7-1964).
3. Cls. (b) and (c) omitted by Act 11 of 1955, s. 4.
4. Subs. by Act 13 of 1964, s. 5, for “under Chapter IV” (w.e.f. 15-9-1964).
9
Drugs and Cosmetics Act, 1940
10
(e) such other matters as may be necessary or expedient to enable the said Laboratory to
carry out its functions;
(f) the matters necessary to be prescribed for the purposes of the proviso to sub-section (1).
7. The Drugs Consultative Committee.—(1) The Central Government may constitute an advisory
committee to be called ―the Drugs Consultative Committee‖ to advise the Central Government, the State
Governments and the Drugs Technical Advisory Board on any other matter tending to secure uniformity
throughout
1
[India] in the administration of this Act.
(2) The Drugs Consultative Committee shall consist of two representatives of the Central
Government to be nominated by that Government and one representative of each State Government to
be nominated by the State Government concerned.
(3) The Drugs Consultative Committee shall meet when required to do so by the Central Government and
shall have power to regulate its own procedure.
2
[7A. Sections 5 and 7 not to apply to Ayurvedic, Siddha or Unani drugs.—Nothing contained in
sections 5 and 7 shall apply to
3
[Ayurvedic, Siddha or Unani] drugs.]
CHAPTER III
4
[IMPORT OF DRUGS AND COSMETICS]
8. Standards of quality.—
5
[(1) For the purposes of this Chapter, the expression ―standard quality‖
means—
(a) in relation to a drug, that the drug complies with the standard set out in
6
[the Second Schedule],
and
(b) in relation to a cosmetic, that the cosmetic compiles with such standard as may be
prescribed].
(2) The Central Government, after consultation with the Board and after giving by notification in the
Official Gazette not less than three months‘ notice of its intention so to do, may by a like notification add to or
otherwise amend
6
[the Second Schedule], for the purposes of this Chapter, and thereupon
6
[the Second
Schedule] shall be deemed to be amended accordingly.
7
[9. Misbranded drugs.—For the purposes of this Chapter a drug shall be deemed to be misbranded—
(a) if it is so coloured, coated, powdered or polished that damage is concealed or if it is made to
appear of better or greater therapeutic value than it really is; or
(b) if it is not labelled in the prescribed manner; or
(c) if its label or container or anything accompanying the drug bears any statement, design or
device which makes any false claim for the drug or which is false or misleading in any particular.]
8
[9A. Adulterated drugs.— For the purposes of this Chapter, a drug shall be deemed to be adulterated.—
(a) if it consists, in whole or in part, of any filthy, putrid or decomposed substance; or
(b) if it has been prepared, packed or stored under insanitary conditions whereby it may
have been contaminated with filth or whereby it may have been rendered injurious to health; or
1. Subs. by Act 3 of 1951, s. 3 and Sch., for ―the States‖.
2. Ins. by Act 13 of 1964, s. 6 (w.e.f. 15-9-1964).
3. Subs. by Act 68 of 1982, s. 2 for certain words (w.e.f. 1-2-1983).
4. Subs. by Act 68 of 1982, s. 4, for ―IMPORT OF DRUGS‖ (w.e.f. 1-2-1983).
5. Subs. by Act 21 of 1962, s. 6, for sub-section (1) (w.e.f. 27-7-1964).
6. Subs. by Act 13 of 1964, s. 7, for ―the Schedule‖ (w..e.f. 15-9-1964).
7. Subs. by Act 68 of 1982, s. 5, for s. 9 (w.e.f. 1-2-1983).
8. Subs. by Act 68 of 1982, s. 6, (w.e.f. 1-2-1983).
Drugs and Cosmetics Act, 1940
(e) such other matters as may be necessary or expedient to enable the said Laboratory to
carry out its functions;
(f) the matters necessary to be prescribed for the purposes of the proviso to sub-section (/).
7. The Drugs Consultative Committee —(/) The Central Government may constitute an advisory
committee to be called “the Drugs Consultative Committee” to advise the Central Government, the State
Governments and the Drugs Technical Advisory Board on any other matter tending to secure uniformity
1
throughout [India] in the administration of this Act.
(2) The Drugs Consultative Committee shall consist of two representatives of the Central
Government to be nominated by that Government and one representative of each State Government to
be nominated by the State Government concermed.
(3) The Drugs Consultative Committee shall meet when required to do so by the Central Government and
shall have power to regulate its own procedure.
*I7A. Sections 5 and 7 not to apply to Ayurvedic, Siddha or Unani drugs.—Nothing contained in
sections 5 and 7 shall apply to *[Ayurvedic, Siddha or Unani] drugs.]
CHAPTER III
4
[IMPORT OF DRUGS AND COSMETICS]
5
8. Standards of quality.— [(/) For the purposes of this Chapter, the expression “standard quality”
means—
6
(a) in relation to a drug, that the drug complies with the standard set out in [the Second Schedule],
and
(b) in relation to a cosmetic, that the cosmetic compiles with such standard as may be
prescribed].
(2) The Central Government, after consultation with the Board and after giving by notification in the
Official Gazette not less than three months’ notice of its intention so to do, may by a like notification add to or
6 6
otherwise amend [the Second Schedule], for the purposes of this Chapter, and thereupon [the Second
Schedule] shall be deemed to be amended accordingly.
;
[9. Misbranded drugs.—For the purposes of this Chapter a drug shall be deemed to be misbranded—
(a) if it is so coloured, coated, powdered or polished that damage is concealed or if it is made to
appear of better or greater therapeutic value than it really is; or
(b) if it is not labelled in the prescribed manner; or
(c) if its label or container or anything accompanying the drug bears any statement, design or
device which makes any false claim for the drug or which is false or misleading in any particular. ]
8
[9A. Adulterated drugs— For the purposes of this Chapter, a drug shall be deemed to be adulterated —
(a) if it consists, in whole or in part, of any filthy, putrid or decomposed substance; or
(b) if it has been prepared, packed or stored under insanitary conditions whereby it may
have been contaminated with filth or whereby it may have been rendered injurious to health; or
1. Subs. by Act 3 of 1951, s. 3 and Sch., for “the States”.
. Ins. by Act 13 of 1964, s. 6 (w.e.f. 15-9-1964).
. Subs. by Act 68 of 1982, s.2 for certain words (w.e.f. 1-2-1983).
. Subs. by Act 68 of 1982, s. 4, for “IMPORT OF DRUGS” (w.e.f. 1-2-1983).
Subs. by Act 21 of 1962, s. 6, for sub-section (/) (w.e.f. 27-7-1964).
. Subs. by Act 13 of 1964, s. 7, for “the Schedule” (w..e.f. 15-9-1964).
. Subs. by Act 68 of 1982, s. 5, for s. 9 (w.e.f. 1-2-1983).
. Subs. by Act 68 of 1982, s. 6, (w.e.f. 1-2-1983). C
A
I
D
A
K
R
W
N
10
Drugs and Cosmetics Act, 1940
11
(c) if its container is composed in whole or in part, of any poisonous or deleterious substance
which may render the contents injurious to health; or
(d) if it bears or contains, for purposes of colouring only, a colour other than one which is
prescribed; or
(e) if it contains any harmful or toxic substance which may render it injurious to health; or
(f) if any substance has been mixed therewith so as to reduce its quality or strength.
9B. Spurious drugs.— For the purposes of this Chapter, a drug shall be deemed to be spurious—
(a) if it is imported under a name which belongs to another drug; or
(b) if it is an imitation of, or a substitute for, another drug or resembles another drug in a manner
likely to deceive or bears upon it or upon its label or container the name of another
drug unless it is plainly and conspicuously marked so as to reveal its true character and its
lack of identity with such other drug; or
(c) if the label or the container bears the name of an individual or company purporting to be the
manufacturer of the drug, which individual or company is fictitious or does not exist; or
(d) if it has been substituted wholly or in part by another drug or substance; or
(e) if it purports to be the product of a manufacturer of whom it is not truly a product.
9C. Misbranded cosmetics.—For the purposes of this chapter, a cosmetic shall be deemed to be
misbranded—
(a) if it contains a colour which is not prescribed; or
(b) if it is not labelled in a prescribed manner; or
(c) if the label or container or anything accompanying the cosmetic bears any statement which is
false or misleading in any particular.
9D. Spurious cosmetics.—For the purposes of this Chapter, a drug shall be deemed to be spurious,—
(a) if it is imported under the name which belongs to another cosmetic; or
(b) if it is an imitation of, or is a substitute for, another cosmetic or resembles another cosmetic in a
manner likely to deceive or bears upon it or upon its label or container the name of another cosmetic,
unless it is plainly or conspicuously marked so as to reveal its true character and its lack of identity with
such other cosmetic; or
(c) if the label or the container bears the name of an individual or company purporting to be the
manufacturer of the cosmetic, which individual or company is fictitious or does not exist; or
(d) if it purports to be the product of a manufacturer of whom it is not truly a product.]
10. Prohibition of import of certain drugs or cosmetics.— From such date
1 as may be fixed by the
Central Government by notification in the Official Gazette in this behalf, no person shall import—
(a) any drug
2
[or cosmetic] which is not of standard quality;
3
[(b) any misbranded drug
4
[or misbranded or spurious cosmetic;]
1. 1st April, 1947 for cls. (a), (b), (c), (e) and (f) and 1st April 1949 for cl. (d) see Notifn. No.18- 12/46-D (I), dated the 11th February 1947, Gazette of
India, 1947, Pt. 1, P. 189 as amended by Notifn. No.F.1-2/48-D (1), dated the 29th September,1948.
1st April, 1953 for the States of Himachal Pradesh, Bilaspur, Kutch, Bhopal,Tripura, Vindhya Pradesh and Manipur; vide Notifn. No. S.R.O. 666,
dated the 30th March, 1953, Gazette of India, 1953, Pt. II, Sec. 3, p.451.
2. Ins. by Act 21 of 1962, s. 8 (w.e.f. 27-7-1964).
3. Subs. by Act 21 of 1962, s. 8, for cl. (b) (w.e.f. 27-7-1964).
4. Subs. by Act 68 of 1982, s.7, for ―or misbranded cosmetic‖ (w.e.f. 1-2-1983).
Drugs and Cosmetics Act, 1940
(c) if its container is composed in whole or in part, of any poisonous or deleterious substance
which may render the contents injurious to health; or
(d) if it bears or contains, for purposes of colouring only, a colour other than one which is
prescribed; or
(e) if it contains any harmful or toxic substance which may render it injurious to health; or
(f) if any substance has been mixed therewith so as to reduce its quality or strength.
9B. Spurious drugs.— For the purposes of this Chapter, a drug shall be deemed to be spurious—
(a) if itis imported under a name which belongs to another drug; or
(b) if it is an imitation of, or a substitute for, another drug or resembles another drug in a manner
likely to deceive or bears upon it or upon its label or container the name of another
drug unless it is plainly and conspicuously marked so as to reveal its true character and its
lack of identity with such other drug; or
(c) if the label or the container bears the name of an individual or company purporting to be the
manufacturer of the drug, which individual or company is fictitious or does not exist; or
(d) if it has been substituted wholly or in part by another drug or substance; or
(e) if it purports to be the product of a manufacturer of whom it is not truly a product.
9C. Misbranded cosmetics.—For the purposes of this chapter, a cosmetic shall be deemed to be
misbranded—
(a) if it contains a colour which is not prescribed; or
(b) if it is not labelled in a prescribed manner; or
(c) if the label or container or anything accompanying the cosmetic bears any statement which is
false or misleading in any particular.
9D. Spurious cosmetics.—For the purposes of this Chapter, a drug shall be deemed to be spurious,—
(a) if it is imported under the name which belongs to another cosmetic; or
(b) if it is an imitation of, or is a substitute for, another cosmetic or resembles another cosmetic in a
manner likely to deceive or bears upon it or upon its label or container the name of another cosmetic,
unless it is plainly or conspicuously marked so as to reveal its true character and its lack of identity with
such other cosmetic; or
(c) if the label or the container bears the name of an individual or company purporting to be the
manufacturer of the cosmetic, which individual or company is fictitious or does not exist; or
(d) if it purports to be the product of a manufacturer of whom it is not truly a product.]
1
10. Prohibition of import of certain drugs or cosmetics.— From such date as may be fixed by the
Central Government by notification in the Official Gazette in this behalf, no person shall import—
2
(a) any drug [or cosmetic] which is not of standard quality;
*[(b) any misbranded drug “[or misbranded or spurious cosmetic;]
1. 1st April, 1947 for cls. (a), (6), (c), (e) and (f) and 1st April 1949 for cl. (d) see Notifn. No.18- 12/46-D (1, dated the 11th February 1947, Gazette of
India, 1947, Pt. 1, P. 189 as amended by Notifn. No.F.1-2/48-D (1), dated the 29th September,1948.
1st April, 1953 for the States of Himachal Pradesh, Bilaspur, Kutch, Bhopal,Tripura, Vindhya Pradesh and Manipur; vide Notifn. No. S.R.O. 666,
dated the 30th March, 1953, Gazette of India, 1953, Pt. II, Sec. 3, p.451.
2. Ins. by Act 21 of 1962, s. 8 (w.e.f. 27-7-1964).
3. Subs. by Act 21 of 1962, s. 8, for cl. (b) (w.e.f. 27-7-1964).
4. Subs. by Act 68 of 1982, s.7, for “or misbranded cosmetic” (w.e.f. 1-2-1983).
11
Drugs and Cosmetics Act, 1940
12
1
[(bb) any
2
[adulterated or spurious] drug;]
(c) any drug
3
[or cosmetic] for the import of which a licence is prescribed, otherwise than under, and
in accordance with, such licence;
4
[(d) any patent or proprietary medicine, unless there is displayed in the prescribed manner on the
label or container thereof
5
[the true formula or list of active ingredients contained in it, together with the
quantities thereof;]
(e) any drug which by means of any statement, design or device accompanying it or by any
other means, purports or claims to cure or mitigate any such disease or ailment, or to have any such other
effect, as may be prescribed;
3
[(ee) any cosmetic containing any ingredient which may render it unsafe or harmful for use
under the directions indicated or recommended;]
(f) any drug
3
[or cosmetic] the import of which is prohibited by rule made under this Chapter:
Provided that nothing in this section shall apply to the import, subject to prescribed conditions, of small
quantities of any drug for the purpose of examination, test or analysis or for personal use:
Provided further that the Central Government may, after consultation with the Board, by notification in the
Official Gazette, permit, subject to any conditions specified in the notification, the import of any drug or class
of drugs not being of standard quality.
6
[* * * * *]
7
Previous and next
Questions people ask
Is rule 10 of Drugs and Cosmetics Rules, 1945 still in force?
No repeal of Drugs and Cosmetics Rules, 1945 is recorded.